Clinical observation of edaravone combined with ginkgo leaf extract and dipyridamole injection in the treatment of acute cerebral infarction
Rongli Rao
Abstract
Rongli Rao
Abstract
Objective To investigate the clinical effect of edaravone combined with ginkgo leaf extract and dipyridamole injection in the treatment of acute cerebral infarction. Methods From January 2016 to September 2017, 100 patients with acute cerebral infarction in Xin′an International Hospital were selected.According to digital table method, the patients were divided into observation group and control group, with 50 cases in each group.The observation group was given edaravone combined with ginkgo leaf extract and dipyridamole injection.The control group received ginkgo leaf extract and dipyridamole injection treatment.The patients were treated for 20 days.The clinical effect of the two groups was compared. Results The total effective rate of the observation group was 90.0%, which was significantly higher than 70.0% in the control group (χ2=16.265, P 0.05). After treatment, the indicators in the two groups were declined.The whole high blood viscosity, whole low blood viscosity, blood plasma viscosity, hematocrit and fibrinogen in the observation group were (5.29±1.25) mPa/s, (12.88±3.35) mPa/s, (1.76±0.28) mPa/s, (0.44±0.48) and (3.48±0.57) g/L, respectively, which were significantly better than those in the control group[(5.83±1.54) mPa/s, (14.54±4.29) mPa/s, (1.89±0.32) mPa/s, (0.47±0.65), (3.76±0.89)g/L], the differences were statistically significant between the two groups(t=5.423, 6.287, 5.112, 9.145, 5.443, all P<0.05). Conclusion Edaravone combined with ginkgo leaf extract and dipyridamole injection in the treatment of acute cerebral infarction has good effect, and it is worth to be widely used in the clinical treatment. Key words: Brain infarction; Edaravin; Ginkgodamme injection
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical effect of edaravone combined with ginkgo leaf extract and dipyridamole injection in the treatment of acute cerebral infarction. Methods From January 2016 to September 2017, 100 patients with acute cerebral infarction in Xin′an International Hospital were selected.According to digital table method, the patients were divided into observation group and control group, with 50 cases in each group.The observation group was given edaravone combined with ginkgo leaf extract and dipyridamole injection.The control group received ginkgo leaf extract and dipyridamole injection treatment.The patients were treated for 20 days.The clinical effect of the two groups was compared. Results The total effective rate of the observation group was 90.0%, which was significantly higher than 70.0% in the control group (χ2=16.265, P 0.05). After treatment, the indicators in the two groups were declined.The whole high blood viscosity, whole low blood viscosity, blood plasma viscosity, hematocrit and fibrinogen in the observation group were (5.29±1.25) mPa/s, (12.88±3.35) mPa/s, (1.76±0.28) mPa/s, (0.44±0.48) and (3.48±0.57) g/L, respectively, which were significantly better than those in the control group[(5.83±1.54) mPa/s, (14.54±4.29) mPa/s, (1.89±0.32) mPa/s, (0.47±0.65), (3.76±0.89)g/L], the differences were statistically significant between the two groups(t=5.423, 6.287, 5.112, 9.145, 5.443, all P<0.05). Conclusion Edaravone combined with ginkgo leaf extract and dipyridamole injection in the treatment of acute cerebral infarction has good effect, and it is worth to be widely used in the clinical treatment. Key words: Brain infarction; Edaravin; Ginkgodamme injection
Key concepts: Medicine, Edaravone, Hematocrit, Dipyridamole, Anesthesia, Fibrinogen, Cerebral infarction, Ginkgo